Page last updated: 2024-10-26

valproic acid and Depressive Disorder, Treatment-Resistant

valproic acid has been researched along with Depressive Disorder, Treatment-Resistant in 7 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research Excerpts

ExcerptRelevanceReference
"The diagnoses were major depressive disorder (n = 15), bipolar I disorder (n = 6), and bipolar II disorder (n = 16)."2.82Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2. ( Kagawa, S; Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Nemoto, K; Suzuki, T, 2016)
" A cautious dosing of AMI with VPA comedication is advisable, and therapeutic drug monitoring should be performed because this combination may lead to a remarkable increase of AMI and NOR serum levels."1.39Interaction of valproic acid and amitriptyline: analysis of therapeutic drug monitoring data under naturalistic conditions. ( Burger, R; Deckert, J; Hohage, A; Pfuhlmann, B; Unterecker, S, 2013)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Unterecker, S1
Burger, R1
Hohage, A1
Deckert, J1
Pfuhlmann, B1
VillaseƱor, A1
Ramamoorthy, A1
Silva dos Santos, M1
Lorenzo, MP1
Laje, G1
Zarate, C1
Barbas, C1
Wainer, IW1
Xu, AJ1
Niciu, MJ1
Lundin, NB1
Luckenbaugh, DA1
Ionescu, DF1
Richards, EM1
Vande Voort, JL1
Ballard, ED1
Brutsche, NE1
Machado-Vieira, R1
Zarate, CA1
Ghabrash, MF1
Comai, S1
Tabaka, J1
Saint-Laurent, M1
Booij, L1
Gobbi, G1
Nakamura, A1
Mihara, K1
Nagai, G1
Kagawa, S1
Suzuki, T1
Nemoto, K1
Kondo, T1
Kasper, S1
McSkimming, AJ1
Dham, P1
Alexander, J1
Dinesh, A1

Trials

3 trials available for valproic acid and Depressive Disorder, Treatment-Resistant

ArticleYear
A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.
    British journal of pharmacology, 2014, Volume: 171, Issue:8

    Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Bipolar Disorder; Cross-Over Studies; Dep

2014
Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
    Neural plasticity, 2015, Volume: 2015

    Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cross-Over Studies; Depressive Disorder, Treatment-R

2015
Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2.
    Therapeutic drug monitoring, 2016, Volume: 38, Issue:3

    Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Chromatograp

2016

Other Studies

4 other studies available for valproic acid and Depressive Disorder, Treatment-Resistant

ArticleYear
Interaction of valproic acid and amitriptyline: analysis of therapeutic drug monitoring data under naturalistic conditions.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:4

    Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Chi-Square Distribution; Delirium; Depressive Dis

2013
Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2016, Volume: 17, Issue:2

    Topics: Adult; Antidepressive Agents; Canada; Depressive Disorder, Treatment-Resistant; Female; Humans; Male

2016
Editorial.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2016, Volume: 17, Issue:2

    Topics: Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Electroconvulsive Therapy; Humans; Psych

2016
Peripheral oedema in quetiapine therapy.
    The Australian and New Zealand journal of psychiatry, 2012, Volume: 46, Issue:8

    Topics: Antimanic Agents; Antipsychotic Agents; Depressive Disorder, Treatment-Resistant; Dibenzothiazepines

2012